211 related articles for article (PubMed ID: 36803698)
1. Development and Implementation of a Pharmacist-Led Proton Pump Inhibitor Deprescribing Algorithm in a Geriatric Ambulatory Office.
Leszcynski L; Bente J
Sr Care Pharm; 2023 Mar; 38(3):105-112. PubMed ID: 36803698
[No Abstract] [Full Text] [Related]
2. Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study.
Whitman A; DeGregory K; Morris A; Mohile S; Ramsdale E
Support Care Cancer; 2018 Dec; 26(12):4105-4113. PubMed ID: 29869294
[TBL] [Abstract][Full Text] [Related]
3. Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study.
Aubert CE; Blum MR; Gastens V; Dalleur O; Vaillant F; Jennings E; Aujesky D; Thompson W; Kool T; Kramers C; Knol W; O'Mahony D; Rodondi N
CMAJ Open; 2023; 11(1):E170-E178. PubMed ID: 36854455
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
[TBL] [Abstract][Full Text] [Related]
5. Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.
Mafi JN; May FP; Kahn KL; Chong M; Corona E; Yang L; Mongare MM; Nair V; Reynolds C; Gupta R; Damberg CL; Esrailian E; Sarkisian C
J Am Geriatr Soc; 2019 Dec; 67(12):2600-2604. PubMed ID: 31486549
[TBL] [Abstract][Full Text] [Related]
6. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
Triantafylidis LK; Hawley CE; Perry LP; Paik JM
Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
[TBL] [Abstract][Full Text] [Related]
7. Successful deprescribing of unnecessary proton pump inhibitors in a primary care clinic.
Odenthal DR; Philbrick AM; Harris IM
J Am Pharm Assoc (2003); 2020; 60(1):100-104. PubMed ID: 31601478
[TBL] [Abstract][Full Text] [Related]
8. Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.
Gerardi S; Sperlea D; Levy SO; Bondurant-David K; Dang S; David PM; Lizotte A; Senécal L; Paquette F; Vanier MC
Am J Health Syst Pharm; 2022 Nov; 79(Suppl 4):S128-S135. PubMed ID: 35881917
[TBL] [Abstract][Full Text] [Related]
9. Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.
Jovevski JJ; Smith CR; Roberts JL; Dev S; Iloabuchi TC; Gruber EA; Williams MJ; Slaven JE; Mitchell AM
Acad Emerg Med; 2023 Apr; 30(4):410-419. PubMed ID: 36794336
[TBL] [Abstract][Full Text] [Related]
10. We have had a gutful: The need for deprescribing proton pump inhibitors.
Naunton M; Peterson GM; Deeks LS; Young H; Kosari S
J Clin Pharm Ther; 2018 Feb; 43(1):65-72. PubMed ID: 28895169
[TBL] [Abstract][Full Text] [Related]
11. Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care.
Thompson W; Hogel M; Li Y; Thavorn K; O'Donnell D; McCarthy L; Dolovich L; Black C; Farrell B
J Am Med Dir Assoc; 2016 Jul; 17(7):673.e1-4. PubMed ID: 27289201
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate proton-pump inhibitor prescribing in primary care - an observational study with quality circles.
Vidonscky Lüthold R; Henz NC; Fuhrer C; Häner A; Schenk M; Jungo KT; Streit S
Swiss Med Wkly; 2023 Sep; 153():40119. PubMed ID: 37769322
[TBL] [Abstract][Full Text] [Related]
13. Deprescribing potential of commonly used medications among community-dwelling older adults: insights from a pharmacist's geriatric assessment.
Bužančić I; Držaić M; Kummer I; Ortner Hadžiabdić M; Brkić J; Fialová D
Sci Rep; 2024 Mar; 14(1):6235. PubMed ID: 38485992
[TBL] [Abstract][Full Text] [Related]
14. Patient and Provider Perspectives on Deprescribing Proton Pump Inhibitors.
Ikeji C; Williams A; Hennawi G; Brandt NJ
J Gerontol Nurs; 2019 Oct; 45(10):9-17. PubMed ID: 31560071
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors.
Reeve E; Andrews JM; Wiese MD; Hendrix I; Roberts MS; Shakib S
Ann Pharmacother; 2015 Jan; 49(1):29-38. PubMed ID: 25385826
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of Student Pharmacists into a Proton Pump Inhibitor Deprescribing Telehealth Program for Rural Veterans.
Bhardwaj S; Garvin S; Kuehl S; Van Epps J; Dunkerson F; Lehmann M; Gruber S; Kieser M; Zhao Q; Portillo E
Innov Pharm; 2022; 13(3):. PubMed ID: 36627915
[No Abstract] [Full Text] [Related]
17. Deprescribing in a family health team: a study of chronic proton pump inhibitor use.
Walsh K; Kwan D; Marr P; Papoushek C; Lyon WK
J Prim Health Care; 2016 Jun; 8(2):164-71. PubMed ID: 27477559
[TBL] [Abstract][Full Text] [Related]
18. Deprescribing potentially inappropriate medications in memory clinic patients (DePIMM): A feasibility study.
Cross AJ; George J; Woodward MC; Le VJ; Elliott RA
Res Social Adm Pharm; 2020 Oct; 16(10):1392-1397. PubMed ID: 32014358
[TBL] [Abstract][Full Text] [Related]
19. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines.
Farrell B; Richardson L; Raman-Wilms L; de Launay D; Alsabbagh MW; Conklin J
Res Social Adm Pharm; 2018 Jan; 14(1):18-25. PubMed ID: 28214150
[TBL] [Abstract][Full Text] [Related]
20. Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study.
Jokanovic N; Aslani P; Carter S; Duong M; Gnjidic D; Jansen J; Le Couteur D; Hilmer S
BMJ Open; 2019 Dec; 9(12):e033303. PubMed ID: 31831548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
